Skip to content

Cognitive Behavioural Therapy for Sexual Concerns During Perimenopause

Cognitive Behavioural Therapy for Sexual Concerns During Perimenopause

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04922385
Enrollment
62
Registered
2021-06-10
Start date
2021-01-01
Completion date
2023-03-31
Last updated
2022-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopause, Sexual Concerns

Brief summary

Given the high rates and associated impairment of sexual concerns during the menopausal transition, and specifically during perimenopause, our team has developed a CBT protocol specifically designed to target these prevalent and distressing sexual concerns. The broad aim of the proposed study is to validate this new protocol in a clinic that provides empirically-supported assessment and intervention services for women with menopause-related symptoms. The primary objective of this study is to evaluate the efficacy of a four-week individual CBT protocol in improving sexual satisfaction and reducing distress during perimenopause. The secondary objective of this study is to evaluate the efficacy of this CBT protocol to improve sexual functioning (e.g., desire, arousal), relationship satisfaction, and body image. Exploratory analyses will examine the impact on this CBT protocol on vasomotor symptoms, depression, and anxiety.

Interventions

OTHERCognitive Behavioural Therapy

This study is an open waitlist control study. Eligible participants will be assigned to a treating clinician and will complete 4 weeks of treatment, followed by a post-treatment assessment (2 weeks later). If a treating clinician is not immediately available, participants will be placed on their waitlist for 4 weeks. They will then be assessed after 4 weeks and undergo the 4 week treatment, followed by the post-treatment assessment (2 weeks later).

Sponsors

St. Joseph's Healthcare Hamilton
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. 40-60 years of age; 2. peri-menopausal and have had a menstrual period within the previous twelve months as per the STRAW definition (Harlow et al., 2012); 3. cut-off score of 26 or lower on the Female Sexual Functioning Index, indicating sexual dysfunction (Wiegel et al., 2005); 4. medication stable (e.g., hormone therapy), with no changes in dosing for the previous three months (Green et al., 2019); 5. no psychological treatment to address sexual dysfunction and/or sexual concerns within the previous six months; and 6. speak, read, and write in English to comprehend testing procedures and written materials in treatment 7. living within Canada

Exclusion criteria

1. participants with psychotic disorders, or current substance and/or alcohol dependence; and 2. participants who are severely depressed/suicidal at time of the intake assessment.

Design outcomes

Primary

MeasureTime frameDescription
Female Sexual Desire Questionnaire (FSDQ)6 weeksThe FSDQ (Goldhammer & McCabe, 2011) is a 50-item self-report questionnaire assessing one's experience of and sexual desire for women across six domains: dyadic desire, solitary desire, resistance, positive relationship, sexual self-image, and concern. Total scores range from 50 to 300, with higher scores indicated increased sexual desire.
Female Sexual Distress Scale-Revised (FSDS-R)6 weeksThe FSDS-R (DeRogatis et al., 2008) is a 13-item self-report questionnaire assessing various aspects of sexual distress, with a clinical cut-off score of 11 indicated sexual distress. Scores on the FSDS-R range from 0 to 48, with higher scores indicating greater sexual distress.
The Female Sexual Function Index (FSFI)6 weeksThe FSFI (Rosen et al., 2000) is a six domain measure of female sexual functioning including sexual desire, subjective arousal, lubrication, orgasm, satisfaction, and pain. Scores on the FSFI range from 2-36, which higher scores indicating a greater level of sexual function.

Secondary

MeasureTime frameDescription
The Greene Climacteric Scale (GCS)6 weeksThe GCS (Greene, 1998) is a self-report questionnaire measuring four menopause-related domains: vasomotor symptoms, depression and anxiety, physical complaints, and sexual concerns. Studies have shown women who score greater than 12 on the GCS are more likely to be menopausal.
The Hot Flash Related Daily Interference Scale (HFRDIS)6 weeksThe HFRDIS (Carpenter, 2001) assesses the degree to which vasomotor symptoms interfere with daily life. Higher scores on the HFRDIS indicate higher interference due to hot flashes and thus, greater impact on quality of life.
The Beck Depression Inventory-II (BDI-II)6 weeksThe BDI-II (Beck et al., 1996) is a self-report questionnaire and one of the most widely used tools for measuring depression. Total scores on the BDI-II range from 0-63, with higher scores indicating increased depressive symptom severity.
The Hamilton Anxiety Scale (HAM-A)6 weeksThe HAM-A (Hamilton, 1959) is a clinician administered questionnaire developed to quantify the severity of anxiety symptomatology and is considered a gold-standard. Total scores on the HAM-A range from 0-56, with greater scores indicating increased anxiety severity.
The Couples Satisfaction Index (CSI)6 weeksThe CSI (Funk & Rogge, 2007) is a 32-item scale designed to measure one's satisfaction in a relationship. Total scores on the CSI range from 0-81, with higher scores indicating greater couples satisfaction.
36-Item Short-Form Health Survey (SF-36)6 weeksThe SF-36 (Ware & Sherbourne, 1992) is a 36-item self-administered questionnaire assessing one's perception of overall health and well-being. Higher scores on each domain indicate a more favourable health state in that area.
Dresden Body Image Questionnaire (DBIQ)6 weeksThe DBIQ (Scheffers et al., 2017) is a 35-item self-report questionnaire assessing one's feelings of their physical appearance across five subscales: body acceptance, sexual fulfillment, physical contact, vitality, and self-aggrandizement. Higher score on the DBIQ indicate a more positive body image.
Cognitive Flexibility Inventory (CFI)6 weeksThe CFI (Dennis & Vander Wal, 2010) is a 20-item self-report questionnaire that assesses three aspects of cognitive flexibility: tendency to perceive difficult situations as controllable, ability to perceive multiple alternative explanations for life occurrences and human behaviour, and ability to generate multiple alternative solutions to difficult situations. Higher scores are indicative of greater cognitive flexibility when encountering stressful situations.

Countries

Canada

Contacts

Primary ContactSheryl M Green, PhD, CPsych
sgreen@stjoes.ca905-522-1155

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026